Prostatic arterial embolization for the treatment of benign prostatic hyperplasia due to large: result in 32 case (>80 gam)

Dr Phan Hoang Giang1, Dr le Van Khanh1, Dr Nguyen Xuan Hien1, Dr Do Huy Hoang2
1 Doctor of Diagnostic Imaging photo, Bach Mai Hospital
2 Resident Doctor Diagnosis image, University of Medicine Hanoi

Main Article Content

Abstract

Background: Currently, large prostate size (>80 g) of benign prostatic hyperplasia still pose technical challenges for surgical treatment with complication such as: hemorrhage, endoscopy syndrome,…
Objective: to explore the safety and efficacy of prostatic arterial embolization as an alternative treatment for patients with lower urinary tract symptoms due to large benign prostatic hyperplasia.
Methods: A total of 32 patients with prostates >80 g were included in the study; all were failure of medical treatment and unsuited for surgery. Prostatic arterial embolization was performed using combination of 250 μm and 400μm particles in size, under local anaesthesia by a unilateral femoral approach. Clinical follow-up was performed using the international prostate
symptoms score (IPSS), quality of life (QoL), peak urinary flow (Qmax), post-void residual volume (PVR), international index of erectile function short form (IIEF-5), prostatic specific antigen (PSA) at 1, 3, 6 month and prostatic volume measured by magnetic resonance imaging at 3 month after intervention.
Results: Prostatic arterial embolization was technically successful in 32 patients (100%). Follow- up data were available for the those patients with a mean follow-up of 6 months. The clinical improvements in IPSS, QoL, Qmax, PVR, and PV at 6 month was 74.1 %, 152%, 68.7%, 92.6 %, and 35.5% (3 months), respectively. The mean IPSS (pre PAE vs post PAE 27.5 vs 7.1; P < 0.01), the mean QoL (4.7 vs 1.7; P < 0.01 ), the mean Qmax (7.5 vs 18.9; P < 0.01), the mean PVR (65 vs 20.3; P < 0.01), and PV (98.0
vs 65.0, with a mean reduction of 33.6 %; P < 0.01 ) at 3 month after PAE were significantly different with respect to baseline. The mean IIEF-5 was not statistically different from baseline. No major complications were noted.
Conclusions: Prostatic arterial embolization is a safe and effective treatment method for patients with with lower urinary tract symptoms due to large volume. Prostatic arterial embolization may play an important role in patients in whom medical therapy has failed, who are not candidates for any surgical treatment.

Article Details

References

1. Rubenstein et al (2008), Transurethral Microwave Thermotherapy of the Prostate (TUMT). eMedicine, 6 February 2008.
2. Choi SY et al (2012) Impact of changing trends in medical therapy on surgery for benign prostatic hyperplasia over two decades. Korean J Urol. 2012;53:23-8.
3. Geavlete B et al (2013). Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison. BJU Int. 2013;111:793– 803.
4. Phan Hoàng Giang, Nguyễn Xuân Hiền, Phạm Minh Thông (2016), đánh giá hiệu quả điều trị tăng sinh lành tính tuyến tiền liệt bằng phương pháp nút động mạch tuyến tiền liệt (2016), Tạp chí Y Học Việt Nam, số đặc biệt, tháng 8, 2016.
5. Francisco C. Carnevale et al (2015), Transurethral Resection of the Prostate Versus Original and PErFecTED Prostate Artery Embolization Due to Benign Prostatic Hyperplasia: Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis. Cardiovascular and Interventional Radiological Society of Europe 2015.
6. Wang et al (2015), Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population, BMC Urology (2015) 15: 33.
7. Nathan E. Frenk et al (2014), MRI Findings After Prostatic Artery Embolization for Treatment of Benign Hyperplasia, AJR:203, October 2014.
8. Francisco C. Carnevale, Airton Mota Moreira, Alberto A. Antunes (2014), The ‘‘PErFecTED Technique’’: Proximal Embolization First, Then Embolize Distal for Benign Prostatic Hyperplasia. Cardiovasc Intervent Radiol (2014) 37:1602-1605.